ArticleResearch square2023

Tumor Response to Stroma-Modifying Therapy: Magnetic Resonance Imaging Findings in Early-Phase Clinical Trials of Pegvorhyaluronidase alpha (PEGPH20).

Andrés M Arias-Lorza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.